Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 1
2010 3
2011 8
2012 6
2013 5
2014 7
2015 4
2016 2
2018 2
2019 3
2020 2
2021 3
2022 4
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Ten years of live surgical broadcast at Charité-MAYO conferences (2010-2019): a systematic evaluation of the surgical outcome.
Altmann J, Chekerov R, Fotopoulou C, Muallem MZ, du Bois A, Cliby W, Dowdy S, Podratz K, Lichtenegger W, Camara O, Tunn R, Cibula D, Kuemmel S, Scambia G, Vergote I, Chiantera V, Pietzner K, Inci MG, Chopra S, Biebl M, Neymeyer J, Blohmer JU, Sehouli J. Altmann J, et al. Among authors: pietzner k. Int J Gynecol Cancer. 2022 Jun 6;32(6):746-752. doi: 10.1136/ijgc-2021-003173. Int J Gynecol Cancer. 2022. PMID: 35383091
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring.
Braicu EI, du Bois A, Sehouli J, Beck J, Prader S, Kulbe H, Eiben B, Harter P, Traut A, Pietzner K, Glaubitz R, Ataseven B, Chekerov R, Keck C, Winkler T, Heikaus S, Gellendin P, Schütz E, Heitz F. Braicu EI, et al. Among authors: pietzner k. Cancers (Basel). 2021 Dec 30;14(1):168. doi: 10.3390/cancers14010168. Cancers (Basel). 2021. PMID: 35008332 Free PMC article.
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
Keunecke C, Kulbe H, Dreher F, Taube ET, Chekerov R, Horst D, Hummel M, Kessler T, Pietzner K, Kassuhn W, Heitz F, Muallem MZ, Lang SM, Vergote I, Dorigo O, Lammert H, du Bois A, Angelotti T, Fotopoulou C, Sehouli J, Braicu EI. Keunecke C, et al. Among authors: pietzner k. Gynecol Oncol. 2022 Aug;166(2):334-343. doi: 10.1016/j.ygyno.2022.06.010. Epub 2022 Jun 21. Gynecol Oncol. 2022. PMID: 35738917
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis.
Nguyen-Sträuli BD, Baum J, Meyer-Wilmes P, Kreklau A, Buschmann C, El Ouardi N, Fotopoulou C, Hummel M, Chekerov R, Braicu E, Sehouli J, Pietzner K. Nguyen-Sträuli BD, et al. Among authors: pietzner k. Int J Gynecol Cancer. 2022 Jul 27:ijgc-2022-003637. doi: 10.1136/ijgc-2022-003637. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35896275
54 results